Geratherm Medical AG

Earnings Release • Mar 10, 2009

News Details

Ad-hoc | 10 March 2009 09:18

Geratherm Medical AG: preliminary business numbers for 2008

Geratherm Medical AG / Preliminary Results

Release of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

DGAP-Adhoc: Geratherm Medical AG - preliminary business numbers for 2008

10th March 2009

Ad-hoc announcement pursuant to Section 15 WpHG (German Securities Trading
Act) transmitted by DGAP - a company of the Equity Story AG. The issuer is
responsible for the contents of this announcement.

• turnover EUR 10.1 million; +14.5 %

• EBIT kEUR +594; -3.7 %

• impairment of securities stocks

• earnings of the parent company shareholders (EAT) EUR -2.9 million;

EPS EUR -0.65

• strong growth expected in 2009

Geschwenda, 10th March 2009 - The turnover of the 2008 business year
increased significantly by 14.5% to reach EUR 10.1 million. The crude
result increased above average by 17.5 % to reach EUR 6.1 million. The
gross margin amounted to 60.5 % of the turnover. The EBIT stood at about
the same level as the previous year.

In view of the financial market turbulences, we undertook value-reductions
on securities due to significant (-20%) or longer lasting (6 months)
reduced stock-exchange prices, within the framework of impairment tests.
Thus, the entire securities stock was value adjusted as per 31 December
2008, except for a smaller position that we sold at a profit at the
beginning of 2009.

The balance resulting from realised gains and value reductions with an
impact on earnings led to a balance-sheet loss of the financial result in
the amount of EUR 3.5 million. The devaluation undertaken comprises
unrealized book losses on securities stocks, which became necessary within
the framework of an impairment test. Should the capital market recover
again, the devalued securities will lead to a balance-sheet gain upon a
sale.

Together with the profit contributions from the operational business, there
will be earnings of the parent company shareholders of EUR -2.9 million or
-65 cents per share recorded for the business year 2008.The Board of
Management and the Supervisory Board suggest a suspension of dividend
payments for the business year 2008.

Detailed business numbers for the year 2008 are scheduled to be published
on 16 April 2009.

Short company profile

Geratherm Medical is an internationally operating medical products
enterprise with the business areas 'Temperature Management', 'Cardio' and
'Respiratory'.

Our company's roots are in temperature measurement in the medical sphere.
In this business area we offer a broad spectrum of products, most of which
have unique selling points. We supply our customers/patients with
high-quality products ranging from thermometers to complex warming systems
for use in the operating theatre and by emergency rescue services. In the
Cardio business area we concentrate on the development of products for the
detection of atrial fibrillation as a measure to prevent strokes. The
Respiratory segment develops and markets products for the assessment of
pulmonary function.

In all three business areas, Geratherm has patent-protected basic
technologies at its disposal. We regard ourselves as a research-based
medical products company with a clear focus on medical diagnostic devices
that generate vital data.

Geratherm shares have been listed in the Prime Standard segment of the
Frankfurt Stock Exchange since the year 2000. Geratherm Medical continues
to be represented in the German Entrepreneurial Index and in the German
Health-Care Index.

Geratherm Medical AG, Investor Relations

Fahrenheitstraße 1, 98716 Geschwenda

Tel. +49 (0)36205/98 111, E-Mail: info@geratherm.com www.geratherm.com

Emittent: Geratherm Medical AG, Fahrenheitstraße 1, 98716 Geschwenda
Deutschland

Tel. 036205/98 111 Fax: 036205/98 115

ISIN : DE 000 549 562 6

WKN : 549 562

Börsen : Frankfurter Wertpapierbörse /Geregelter Markt/Prime Standard

Börse: Freiverkehr in Berlin-Bremen, Düsseldorf, Hamburg, München,
Stuttgart

• Ende der Mitteilung -
  10.03.2009 Financial News transmitted by DGAP

---

Language: English
Issuer: Geratherm Medical AG
Fahrenheitstraße 1
98716 Geschwenda
Deutschland
Phone: +49 (0)36205 98-0
Fax: +49 (0)36205 98-1 15
E-mail: info@geratherm.com
Internet: www.geratherm.com
ISIN: DE0005495626
WKN: 549562
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, München, Stuttgart

End of News DGAP News-Service

---